Cargando…

Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response

BACKGROUND: Immune checkpoint blockade (ICB) therapies have changed the paradigm of cancer therapies. However, anti-tumor response of the ICB is insufficient for many patients and limited to specific tumor types. Despite many preclinical and clinical studies to understand the mechanism of anti-tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Yosuke, Fu, Yu, Liu, Hong, Lee, Min Young, Shaw, Michael H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590766/ https://www.ncbi.nlm.nih.gov/pubmed/34774008 http://dx.doi.org/10.1186/s12885-021-08974-3

Ejemplares similares

Comparison of cisplatin-induced anti-tumor response in CT26 syngeneic tumors of three BALB/c substrains
por: Gong, Jeong Eun, et al.
Publicado: (2021)

Anti‑tumor effects of an aqueous extract of Ecklonia cava in BALB/cKorl syngeneic mice using colon carcinoma CT26 cells
por: Gong, Jeong Eun, et al.
Publicado: (2023)

Effect of ART1 on the proliferation and migration of mouse colon carcinoma CT26 cells in vivo
por: Xu, Jian-Xia, et al.
Publicado: (2017)

Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models
por: Waaler, Jo, et al.
Publicado: (2020)

Dendritic cells loaded with CD44(+) CT-26 colon cell lysate evoke potent antitumor immune responses
por: Fu, Changhao, et al.
Publicado: (2019)

GM-CSF augmented the photothermal immunotherapeutic outcome of self-driving gold nanoparticles against a mouse CT-26 colon tumor model
por: Dai, Jie, et al.
Publicado: (2023)

Anti-Cancer Effects of α-Cubebenoate Derived from Schisandra chinensis in CT26 Colon Cancer Cells
por: Gong, Jeong Eun, et al.
Publicado: (2022)

Different syngeneic tumors show distinctive intrinsic tumor-immunity and mechanisms of actions (MOA) of anti-PD-1 treatment
por: Jin, Ying, et al.
Publicado: (2022)

Lentinan Enhances Sensitivity of Mouse Colon 26 Tumor to cis‐Diamminedichloroplatinum(II) and Decreases Glutathione Transferase Expression
por: Murata, Tetsuo, et al.
Publicado: (1996)

TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response
por: Zeng, Zexian, et al.
Publicado: (2021)

5-Fluorouracil Treatment of CT26 Colon Cancer Is Compromised by Combined Therapy with IMMODIN
por: Demeckova, Vlasta, et al.
Publicado: (2022)

Quantitative microscopy of mouse colon 26 cells growing in different metastatic sites.
por: Vidal-Vanaclocha, F., et al.
Publicado: (1991)

Recombinant KRAS G12D Protein Vaccines Elicit Significant Anti-Tumor Effects in Mouse CT26 Tumor Models
por: Wan, Yuhua, et al.
Publicado: (2020)

Antitumor Effects and Immunomodulating Activities of Phellinus linteus Extract in a CT-26 Cell-Injected Colon Cancer Mouse Model
por: Yang, Byung-Keun, et al.
Publicado: (2009)

Tumor-Derived Exosomes Enriched by miRNA-124 Promote Anti-tumor Immune Response in CT-26 Tumor-Bearing Mice
por: Rezaei, Ramazan, et al.
Publicado: (2021)

Molecular and Immune Profiling of Syngeneic Mouse Models Predict Response to Immune Checkpoint Inhibitors in Gastric Cancer
por: Lee, Dagyeong, et al.
Publicado: (2023)

Chidamide plus Tyrosine Kinase Inhibitor Remodel the Tumor Immune Microenvironment and Reduce Tumor Progression When Combined with Immune Checkpoint Inhibitor in Naïve and Anti-PD-1 Resistant CT26-Bearing Mice
por: Chen, Jia-Shiong, et al.
Publicado: (2022)

Zoledronic Acid Regulates Autophagy and Induces Apoptosis in Colon Cancer Cell Line CT26
por: Zhu, Jinhua, et al.
Publicado: (2017)

Apoptosis inducing capacity of Holothuria arenicola in CT26 colon carcinoma cells in vitro and in vivo
por: Baharara, Javad, et al.
Publicado: (2016)

Machine learning on syngeneic mouse tumor profiles to model clinical immunotherapy response
por: Zeng, Zexian, et al.
Publicado: (2022)

Combination of GD2-directed bispecific trifunctional antibody therapy with Pd-1 immune checkpoint blockade induces anti-neuroblastoma immunity in a syngeneic mouse model
por: Ivasko, Sara Marie, et al.
Publicado: (2023)

Repeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model
por: Wu, Yanhong, et al.
Publicado: (2016)

Anti-tumor effect of aquaporin 3 monoclonal antibody on syngeneic mouse tumor model
por: Tanaka, Manami, et al.
Publicado: (2022)

Ectopically Expressed Membrane-bound Form of IL-9 Exerts Immune-stimulatory Effect on CT26 Colon Carcinoma Cells
por: Do Thi, Van Anh, et al.
Publicado: (2018)

Synthesis of Four Steroidal Carbamates with Antitumor Activity against Mouse Colon Carcinoma CT26WT Cells: In Vitro and In Silico Evidence
por: Pacheco, Daylin Fernández, et al.
Publicado: (2022)

Induction of Apoptosis and Cell Cycle Arrest in Mouse Colon 26 Cells by Benastatin A
por: Kakizaki, Ikuko, et al.
Publicado: (2000)

Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models
por: Gutierrez, Wade R., et al.
Publicado: (2021)

Preventive and Antiproliferative Effects of Tumor Necrosis Factor against Experimental Hepatic Metastases of Mouse Colon‐26 Tumor
por: Nishiyama, Yoshitaka, et al.
Publicado: (1989)

Intratumoral Administration of High-Concentration Nitric Oxide and Anti-mPD-1 Treatment Improves Tumor Regression Rates and Survival in CT26 Tumor-Bearing Mice
por: Confino, Hila, et al.
Publicado: (2023)

Immunopotentiator Aikejia improves the therapeutic efficacy of PD-1/PD-L1 immunosuppressive pathway in CT26.WT cancer cell
por: Huang, Chaoqun, et al.
Publicado: (2019)

Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model
por: Garofalo, Mariangela, et al.
Publicado: (2021)

Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model
por: Piranlioglu, Raziye, et al.
Publicado: (2019)

Impact of Preexisting Anti–Adenovirus 26 Humoral Immunity on Immunogenicity of the Ad26.COV2.S Coronavirus Disease 2019 Vaccine( )
por: Le Gars, Mathieu, et al.
Publicado: (2022)

Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors
por: Villars, Fabienne O., et al.
Publicado: (2017)

Ferulic Acid Induces Autophagy and Apoptosis in Colon Cancer CT26 Cells via the MAPK Pathway
por: Chen, Shanbin, et al.
Publicado: (2023)

Remodeling of energy metabolism by a ketone body and medium-chain fatty acid suppressed the proliferation of CT26 mouse colon cancer cells
por: Kadochi, Yui, et al.
Publicado: (2017)

Liposomal β-Sitosterol Suppresses Metastasis of CT26/luc Colon Carcinoma via Inhibition of MMP-9 and Evoke of Immune System
por: Shen, Chao-Yu, et al.
Publicado: (2022)

Radiation Responses of Subrenally Transplanted Syngeneic and Allogeneic Mouse Fibrosarcomas
por: Sato, Setsu, et al.
Publicado: (1988)

Anticancer Effect of Cold Atmospheric Plasma in Syngeneic Mouse Models of Melanoma and Colon Cancer
por: Jung, Joon-Min, et al.
Publicado: (2023)

Proteomic analysis of tumor tissue in CT-26 implanted BALB/C mouse after treatment with ascorbic acid
por: Lee, Jihye, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_004v73lfvst7salpkjuglgc180